STOCK TITAN

Freightos (CRGO) CTO sells 2,528 shares, retains RSUs and options

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Freightos Ltd Chief Technology Officer Enric Alventosa Abril reported selling 2,528 ordinary shares on July 16, 2026 at $1.28 per share, in sales used to cover tax liabilities from vesting RSU grants. Following these trades he directly holds 1,394 shares from a 30,820‑RSU grant, 16,774 RSUs and/or underlying shares from a 35,480‑RSU grant, 25,000 RSUs/underlying shares from a 2025 grant, and stock options over 42,217, 58,048 and 35,181 underlying ordinary shares at exercise prices of $8.44 and $4.17.

Positive

  • None.

Negative

  • None.
Insider Alventosa Abril Enric
Role Chief Technology Officer
Sold 2,528 shs ($3K)
Type Security Shares Price Value
Sale Ordinary Shares F1, F2 1,175 $1.28 $2K
Sale Ordinary Shares F1, F3, F4 1,353 $1.28 $2K
holding Stock Option (right to buy) F5 -- -- --
holding Stock Option (right to buy) F5 -- -- --
holding Stock Option (right to buy) F5, F7 -- -- --
holding Ordinary Shares F5, F6 -- -- --
Holdings After Transaction: Ordinary Shares — 41,774 shares (Direct); Stock Option (right to buy) — 135,446 shares (Direct)
Footnotes (7)
  1. F1. The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.
  2. F2. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 30,820 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2023. Such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) are now fully vested and have been settled for underlying ordinary shares. In addition to the 1,175 shares sold as reported in this row, the 2,904 shares from this grant sold on May 28, 2026 as reported in the Form 4 filed on June 1, 2026, and the 1,170 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 24,177 shares were sold (in certain cases, to cover tax liability) previously (before the Reporting Person was subject to Section 16), such that only 1,394 ordinary shares are currently held by the Reporting Person from the 30,820 RSUs originally granted.
  3. F3. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 35,480 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2024. Such RSUs vest in accordance with the following schedule: 33.33% of those RSUs vested upon the one-year anniversary of the vesting commencement date and the remaining RSUs vest equally on a quarterly basis over the following ten quarters (6.66% per quarter) such that all such RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by December 31, 2027.
  4. F4. In addition to the 1,353 shares sold as reported in this row, and the 1,347 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 16,006 shares were sold (in certain cases, to cover tax liability) previously (before the Reporting Person was subject to Section 16), such that only 16,774 RSUs and/or underlying ordinary shares are currently held by the Reporting Person from the 35,480 RSUs originally granted.
  5. F5. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
  6. F6. The ordinary shares reported in this row consist of shares underlying 25,000 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 31, 2026.
  7. F7. The stock options reported in this row granted by the Issuer to the Reporting Person began vesting (and becoming exercisable for underlying ordinary shares) on October 1, 2022, in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the vesting commencement date and the remaining options vest equally on a quarterly basis over the following twelve quarters (6.125% per quarter) such that all such options will be vested by the four-year anniversary of the vesting commencement date.
Shares sold 2,528 ordinary shares Total ordinary shares sold on July 16, 2026 to cover RSU tax liability
Sale price $1.2800 per share Price per ordinary share for July 16, 2026 sales
Post-sale holdings from 30,820 RSU grant 1,394 ordinary shares Remaining from 30,820 RSUs after prior sales and July 16, 2026 sale
Post-sale holdings from 35,480 RSU grant 16,774 RSUs and/or ordinary shares Remaining from 35,480 RSUs after sales including July 16, 2026
2025 RSU grant 25,000 RSUs/underlying shares RSUs vesting in full and settling into shares by December 31, 2026
Stock option position 1 42,217 underlying shares at $8.4400 Options expiring November 2, 2032, held directly
Stock option position 2 58,048 underlying shares at $4.1700 Options expiring February 17, 2032, held directly
Stock option position 3 35,181 underlying shares at $4.1700 Options expiring April 27, 2031, held directly
restricted share units ("RSUs") financial
"sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs")"
Section 16 regulatory
"previously (before the Reporting Person was subject to Section 16), such that only 1,394 ordinary shares are currently held"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
vesting commencement date financial
"25% of those RSUs vested upon the one-year anniversary of the vesting commencement date and the remaining RSUs vest equally"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider share sales did Freightos (CRGO) CTO Enric Alventosa Abril report?

He reported selling 2,528 ordinary shares on July 16, 2026 at $1.28 per share. Footnotes state these transactions were executed on his behalf to cover tax liabilities arising from the vesting of restricted share unit (RSU) grants awarded by Freightos.

How many Freightos (CRGO) shares does the CTO hold after these sales?

After the reported sales, he holds 1,394 ordinary shares from a 30,820‑RSU grant and 16,774 RSUs and/or underlying ordinary shares from a 35,480‑RSU grant. He also has 25,000 RSUs/underlying shares from a separate 2025 grant still vesting.

What RSU grants to the Freightos (CRGO) CTO are described in the filing?

The filing describes RSU grants of 30,820 and 35,480 units, plus a 25,000‑RSU grant that began vesting March 13, 2025. The 35,480‑RSU grant vests 33.33% after one year, then 6.66% quarterly, completing by December 31, 2027.

What stock options does the Freightos (CRGO) CTO retain?

He retains stock options over 42,217 underlying shares at an exercise price of $8.44 expiring November 2, 2032. He also holds options over 58,048 and 35,181 underlying shares at an exercise price of $4.17, expiring in 2032 and 2031 respectively.

Were the Freightos (CRGO) CTO’s reported share sales under a Rule 10b5-1 plan?

The filing’s Rule 10b5‑1 checkbox is not marked as using a trading plan. Footnotes instead explain that the July 16, 2026 sales were made on his behalf specifically to cover tax liabilities associated with the vesting of his RSU awards.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Alventosa Abril Enric

(Last)(First)(Middle)
C/O FREIGHTOS LIMITED, PLANTA 10
AVDA. DIAGONAL, 211

(Street)
BARCELONA08018

(City)(State)(Zip)

SPAIN

(Country)
2. Issuer Name and Ticker or Trading Symbol
Freightos Ltd [ CRGO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Technology Officer
2a. Foreign Trading Symbol
[N/A]
3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares07/16/2026S(1)1,175D$1.281,394(2)D
Ordinary Shares07/16/2026S(1)1,353D$1.2816,774(3)(4)D
Ordinary Shares(5)25,000(6)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)(5)$4.1704/01/202504/27/2031Ordinary Shares35,18135,181D
Stock Option (right to buy)(5)$4.1701/01/202602/17/2032Ordinary Shares58,04858,048D
Stock Option (right to buy)(5)$8.44 (7)11/02/2032Ordinary Shares42,21742,217D
Explanation of Responses:
1. The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.
2. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 30,820 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2023. Such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) are now fully vested and have been settled for underlying ordinary shares. In addition to the 1,175 shares sold as reported in this row, the 2,904 shares from this grant sold on May 28, 2026 as reported in the Form 4 filed on June 1, 2026, and the 1,170 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 24,177 shares were sold (in certain cases, to cover tax liability) previously (before the Reporting Person was subject to Section 16), such that only 1,394 ordinary shares are currently held by the Reporting Person from the 30,820 RSUs originally granted.
3. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 35,480 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2024. Such RSUs vest in accordance with the following schedule: 33.33% of those RSUs vested upon the one-year anniversary of the vesting commencement date and the remaining RSUs vest equally on a quarterly basis over the following ten quarters (6.66% per quarter) such that all such RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by December 31, 2027.
4. In addition to the 1,353 shares sold as reported in this row, and the 1,347 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 16,006 shares were sold (in certain cases, to cover tax liability) previously (before the Reporting Person was subject to Section 16), such that only 16,774 RSUs and/or underlying ordinary shares are currently held by the Reporting Person from the 35,480 RSUs originally granted.
5. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
6. The ordinary shares reported in this row consist of shares underlying 25,000 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 31, 2026.
7. The stock options reported in this row granted by the Issuer to the Reporting Person began vesting (and becoming exercisable for underlying ordinary shares) on October 1, 2022, in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the vesting commencement date and the remaining options vest equally on a quarterly basis over the following twelve quarters (6.125% per quarter) such that all such options will be vested by the four-year anniversary of the vesting commencement date.
Remarks:
Exhibit List: Exhibit 24.1 - Power of Attorney.
/s/ Max Sitnick, Attorney-in-fact07/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)